Get started
Author

Elodie Czuba

Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system
2018 · Elodie Czuba, Mouhamadou Diop, et al. · International Journal of Pharmaceutics · 60
Enhanced CRISPR-Cas9 RNA system delivery using cell penetrating peptides-based nanoparticles for efficient in vitro and in vivo applications
2024 · Veronica Guzman Gonzalez, Audrey Grunenberger, et al. · Journal of Controlled Release · 30
Glycaemic control in diabetic rats treated with islet transplantation using plasma combined with hydroxypropylmethyl cellulose hydrogel
2019 · Anaïs Schaschkow, Séverine Sigrist, et al. · Acta Biomaterialia · 23
PDF
Targeted photodynamic therapy for pancreatic cancer: recent innovations from fundamentals to in vivo and clinical applications (2020–2025)
2026 · Souleymane Sarr, Jérémy Godard, et al. · Chemical Communications · 8
PDF
Overcoming the limits of pediatric brain tumor radiotherapy: The use of preclinical 3D models
2024 · Élodie Czuba, Marlène Deschuyter, et al. · Cancer/Radiothérapie · 5
p53 mRNA rescue of tumor suppressor function prevents tumor growth and restores PARPi sensitivity in p53-deficient cancers in vitro and in vivo
2022 · G. Divita, E. Czuba, et al. · European Journal of Cancer · 3
PDF
Abstract 550: p53 rescue of tumor suppressor function with ADGN-531 causes tumor regression both as single agent and in combination with PARPi and KRASG12Cinhibitors
2023 · Gilles Divita, Audrey Grunenberger, et al. · Cancer Research · 1
Abstract 1826: CRISPR mediated KRAS mutant gene editing in pancreatic and colorectal cancer therapy
2020 · Gilles Divita, Elodie Czuba, et al. · Cancer Research · 1
Author response for "Targeted Photodynamic Therapy for Pancreatic Cancer: Recent Innovations from Fundamentals to In Vivo and Clinical Applications (2020-2025)"
2025 · Souleymane Sarr, Jérémy Godard, et al. · Publons reviews and discussion
Abstract 7236: Selective deletion of the KRAS mutant gene with ADGN-123 and ADGN-121 peptide-RNA nanoparticles: A new strategy to overcome acquired resistance to KRASG12C and KRASG12D small molecule inhibitors
2024 · Gilles Divita, Audrey Grunenberger, et al. · Cancer Research
Abstract 640: In vivo rescue of p53 tumor suppressor function with ADGN-531 across Pan-p53 alterations
2024 · Gilles Divita, Audrey Grunenberger, et al. · Cancer Research
Abstract 1717: KRAS mutant gene editing prevents tumor growth in vivo and overcomes acquired resistance to KRASG12C inhibitor
2023 · Gilles Divita, Veronica Guzman-Gonzales, et al. · Cancer Research
Développement de nouveaux systèmes nanoparticulaires pour l'administration de bio-médicaments par voie orale
2018 · Elodie Czuba · theses.fr (ABES)
PDF
Validation of a major modification of the mobile phase in the European Pharmacopoeia LC-UV human insulin assay
2018 · Elodie Czuba, Diane Julien-David, et al. · Journal of Liquid Chromatography & Related Technologies
The charge effect of insulin PLGA nanoparticles on cell uptake in vitro and bioavailability in vivo
2017 · czuba elodie
Works count: 15
Citation count: 131
H-index: 5
I10-index: 3
Year
Topic
Type